
SUVRETTA CAPITAL MANAGEMENT, LLC
Latest 13F filing data - Q1 2026
Holdings (Top positions)
| Stock | Ticker | ||
|---|---|---|---|
![]() | CMPX | 14.31M | $75.69M |
![]() | PROK | 12.34M | $22.09M |
![]() | ARQT | 12.33M | $290.42M |
![]() | BNTC | 11.55M | $122.99M |
![]() | IMTX | 11.19M | $110.11M |
![]() | BHVN | 10.29M | $87.03M |
![]() | ZURA | 9.07M | $53.95M |
![]() | KURA | 8.58M | $69.72M |
![]() | EYPT | 8.30M | $106.94M |
![]() | IFRX | 7.93M | $7.10M |
![]() | LEGN | 7.58M | $137.14M |
![]() | FULC | 6.56M | $50.32M |
![]() | RCUS | 5.03M | $108.67M |
![]() | KALV | 4.77M | $95.99M |
![]() | AVBP | 4.40M | $101.53M |
![]() | AURA | 4.37M | $29.25M |
![]() | GLUE | 4.23M | $69.53M |
![]() | REPL | 4.22M | $32.30M |
![]() | MANE | 4.17M | $263.27M |
![]() | CAPR | 3.82M | $116.09M |

Compass Therapeutics, Inc.
CMPX
Shares Held
14.31M
Value
$75.69M

ProKidney Corp.
PROK
Shares Held
12.34M
Value
$22.09M

Arcutis Biotherapeutics, Inc.
ARQT
Shares Held
12.33M
Value
$290.42M

Benitec Biopharma Inc.
BNTC
Shares Held
11.55M
Value
$122.99M

Immatics N.V.
IMTX
Shares Held
11.19M
Value
$110.11M

Biohaven Ltd.
BHVN
Shares Held
10.29M
Value
$87.03M

Zura Bio Limited
ZURA
Shares Held
9.07M
Value
$53.95M

Kura Oncology, Inc.
KURA
Shares Held
8.58M
Value
$69.72M

EyePoint Pharmaceuticals, Inc.
EYPT
Shares Held
8.30M
Value
$106.94M

InflaRx N.V.
IFRX
Shares Held
7.93M
Value
$7.10M

Legend Biotech Corporation
LEGN
Shares Held
7.58M
Value
$137.14M

Fulcrum Therapeutics, Inc.
FULC
Shares Held
6.56M
Value
$50.32M

Arcus Biosciences, Inc.
RCUS
Shares Held
5.03M
Value
$108.67M

KalVista Pharmaceuticals, Inc.
KALV
Shares Held
4.77M
Value
$95.99M

ArriVent BioPharma, Inc. Common Stock
AVBP
Shares Held
4.40M
Value
$101.53M

Aura Biosciences, Inc.
AURA
Shares Held
4.37M
Value
$29.25M

Monte Rosa Therapeutics, Inc.
GLUE
Shares Held
4.23M
Value
$69.53M

Replimune Group, Inc.
REPL
Shares Held
4.22M
Value
$32.30M

Veradermics, Incorporated
MANE
Shares Held
4.17M
Value
$263.27M

Capricor Therapeutics, Inc.
CAPR
Shares Held
3.82M
Value
$116.09M
